SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000053417-15-000083
Filing Date
2015-02-10
Accepted
2015-02-10 13:30:47
Documents
1

Document Format Files

Seq Description Document Type Size
1 13G INITIAL MONTHLY FILING - EPRS eprs0115.txt SC 13G 8139
  Complete submission text file 0000053417-15-000083.txt   9980
Mailing Address 466 LEXINGTON AVE NEW YORK NY 10017
Business Address 466 LEXINGTON AVE NEW YORK NY 10017 2124211000
JENNISON ASSOCIATES LLC (Filed by) CIK: 0000053417 (see all company filings)

IRS No.: 132631108 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 699 BOYLSTON ST 11TH FLOOR BOSTON MA 02116
Business Address 699 BOYLSTON ST 11TH FLOOR BOSTON MA 02116 617-600-4164
EPIRUS Biopharmaceuticals, Inc. (Subject) CIK: 0001135906 (see all company filings)

IRS No.: 043514457 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-81444 | Film No.: 15592428
SIC: 2834 Pharmaceutical Preparations